Q2 2023 13F Holders as of 30 Jun 2023
-
Type / Class
-
Equity / Common Stock, $0.00001 par value per share
-
Shares outstanding
-
54,965,124
-
Number of holders
-
72
-
Total 13F shares, excl. options
-
16,061,952
-
Shares change
-
+2,706,385
-
Total reported value, excl. options
-
$118,696,041
-
Value change
-
+$17,919,115
-
Put/Call ratio
-
229%
-
Number of buys
-
50
-
Number of sells
-
21
-
Price
-
$7.39
Institutional Holders of Akoya Biosciences, Inc. - Common Stock, $0.00001 par value per share (AKYA) as of Q2 2023
As of 30 Jun 2023 Akoya Biosciences, Inc. - Common Stock, $0.00001 par value per share (AKYA) had 85 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC).
These institutions held a total of 16,061,952 shares of stock of the company.
Largest 10 holders included Blue Water Life Science Advisors, LP, Polar Capital Holdings Plc, VANGUARD GROUP INC, BlackRock Inc., Board of Trustees of The Leland Stanford Junior University, Uniplan Investment Counsel, Inc., MILLENNIUM MANAGEMENT LLC, SVB WEALTH LLC, Granahan Investment Management, LLC, and Parkman Healthcare Partners LLC.
This table shows 85 institutional shareholders of the security as of 30 Jun 2023.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price $ |
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.